Arvinas Inc (ARVN) Reports Q3 2023 Financial Results and Provides Corporate Update
Company Continues Enrollment in Key Trials, Prioritizes Phase 3 Trial with ARV-766, and Reports Cash Position of $1,004.0 Million
Source: yahoo.com
Page 9 - Phase 3 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Phase 3. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Phase 3 Today - Breaking & Trending Today
Switching with Adalimumab Biosimilar Maintains Benefit for Plaque Psoriasis
Trial data support multiple switching between biosimilar and reference product over a 48-week course for the treatment of psoriasis.
Source: hcplive.com
Spironolactone Misses Mark in Hemodialysis Trial
Primary results presented at ASN Kidney Week 2023 showed spironolactone missed the trial's primary endpoint.
Source: hcplive.com
Atrasentan Achieves Positive Topline Results in Phase 3 Trial for IgA Nephropathy
Atrasentan demonstrated superiority versus placebo for reduction in proteinuria through 36 weeks.
Source: hcplive.com
Andreas Kremer, MD, PhD, MHBA: Seladelpar for the Treatment of PBC
Kremer discusses new ad hoc findings from the phase 3 ENHANCE trial showing seladelpar's unique effect on pruritus in patients with PBC.
Source: hcplive.com